---
document_datetime: 2023-09-21 19:11:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kiovig-epar-all-authorised-presentations_en.pdf
document_name: kiovig-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1663783
conversion_datetime: 2025-12-20 16:02:29.234479
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of Administration   | Packaging    | Content     | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|--------------|-------------|----------------|
| EU/1/05/329/001 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 1 g/10 ml   | 1 vial         |
| EU/1/05/329/002 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 2.5 g/25 ml | 1 vial         |
| EU/1/05/329/003 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 5 g/50 ml   | 1 vial         |
| EU/1/05/329/004 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 10 g/100 ml | 1 vial         |
| EU/1/05/329/005 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 20 g/200 ml | 1 vial         |
| EU/1/05/329/006 | Kiovig          | 100 mg/ml  | Solution for infusion | Intravenous use           | vial (glass) | 30 g/300 ml | 1 vial         |